Amit Lodha

AL

Statistics

Publications

2

Citations

36

H-Index

2

Active since

2022

Amit Lodha is an author at Novartis (United States) specializing in intravitreal anti-vascular endothelial growth factor therapy, retinopathy of prematurity, and retinal angiogenesis inhibition.

Publications per year

2022–2024

2

Publications

2